Tag: Drug Pricing

Health Insurers Opt-Out of BALANCE Model and Its Implications

Major health insurers like United Health and Aetna opt-out of BALANCE model, posing challenges for GLP-1 access & Medicare prices. Explore potential impacts.

Proposed Senate Bill to Reduce Drug Expenses for Medicare Beneficiaries

A new Senate bill aims to lower prescription drug costs for Medicare beneficiaries by prioritizing affordable generics and biosimilars, providing potential savings.

Impact of Generic Drugs and Biosimilars on Healthcare Costs

Explore the key impact of generic drugs and biosimilars on reducing prescription costs in the U.S. healthcare system, including legislative efforts and market dynamics.

Lowering Prescription Drug Costs: The Most Favored Nation Proposal

Explore the MFN proposal to lower prescription drug costs while ensuring healthcare innovation and leadership in America.

Reforming U.S. Healthcare: Key Strategies for Cost Reduction

Explore key strategies for reducing U.S. healthcare costs and improving insurance participation. Learn about proposed reforms and bipartisan cooperation in healthcare.

UCB Invests in Atlanta Manufacturing; Florida EXTENDS HIV Med Access

UCB's $2B investment in Atlanta and Florida's HIV medication expansion highlight key health industry trends. Explore the impacts and implications for healthcare.

Concerns About Prescription Drug Prices and Regulatory Solutions

Explore public concerns about prescription drug costs, the impact of TrumpRx, and the necessity for stronger regulations to ensure affordability for all.

Impact of Inflation Reduction Act on Medicare Part D Beneficiaries

Discover how the Inflation Reduction Act benefits Medicare Part D by reducing prescription costs and improving health outcomes for beneficiaries.

Medicare Drug Plans and Eli Lilly's $50 Cap Controversy

Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.

Impact of Trump's Healthcare Policies on Insurance Costs and Access

Explore the critique of Trump’s healthcare policies and their impact on insurance costs and access. Understand the implications for families and consumers.